Literature DB >> 7831992

Psychopathology in Huntington's disease patients.

R Shiwach1.   

Abstract

A retrospective study of 30 Huntington's disease families (110 patients: 75 alive and 35 dead) known to a regional genetic centre, using multiple sources of information, showed the minimum lifetime prevalence of depression to be 39% in the prodrome and the diagnosed disease phase of the illness. The frequency of symptomatic schizophrenia was found to be about 9% and significant personality changes were found in 72% of the sample, some of them leading to gross behavioural anomalies. The findings reinforce the point that depression and schizophrenia, unaccompanied or preceded by organic personality changes and/or very early neural symptoms, are unlikely to lead to the eventual manifestation of the disease.

Entities:  

Mesh:

Year:  1994        PMID: 7831992     DOI: 10.1111/j.1600-0447.1994.tb01587.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  23 in total

Review 1.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

2.  Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.

Authors:  Noelle E Carlozzi; Siera Goodnight; Anna L Kratz; Julie C Stout; Michael K McCormack; Jane S Paulsen; Nicholas R Boileau; David Cella; Rebecca E Ready
Journal:  J Huntingtons Dis       Date:  2019

3.  Psychiatric disorders in preclinical Huntington's disease.

Authors:  Camille L Julien; Jennifer C Thompson; Sue Wild; Pamela Yardumian; Julie S Snowden; Gwen Turner; David Craufurd
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-18       Impact factor: 10.154

Review 4.  An overview of psychiatric symptoms in Huntington's disease.

Authors:  K E Anderson; K S Marder
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

Review 5.  How vital is sleep in Huntington's disease?

Authors:  Anna O G Goodman; Roger A Barker
Journal:  J Neurol       Date:  2010-03-24       Impact factor: 4.849

6.  Neuropsychiatric aspects of Huntington's disease.

Authors:  J S Paulsen; R E Ready; J M Hamilton; M S Mega; J L Cummings
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

7.  Secondary psychoses: an update.

Authors:  Matcheri S Keshavan; Yoshio Kaneko
Journal:  World Psychiatry       Date:  2013-02       Impact factor: 49.548

Review 8.  Imaging Genetics and Genomics in Psychiatry: A Critical Review of Progress and Potential.

Authors:  Ryan Bogdan; Betty Jo Salmeron; Caitlin E Carey; Arpana Agrawal; Vince D Calhoun; Hugh Garavan; Ahmad R Hariri; Andreas Heinz; Matthew N Hill; Andrew Holmes; Ned H Kalin; David Goldman
Journal:  Biol Psychiatry       Date:  2017-01-13       Impact factor: 13.382

9.  Developmental Delay, Treatment-Resistant Psychosis, and Early-Onset Dementia in a Man With 22q11 Deletion Syndrome and Huntington's Disease.

Authors:  Martilias Farrell; Maya Lichtenstein; James J Crowley; Dawn M Filmyer; Gabriel Lázaro-Muñoz; Rita A Shaughnessy; Ian R Mackenzie; Veronica Hirsch-Reinshagen; Robert Stowe; James P Evans; Jonathan S Berg; Jin Szatkiewicz; Richard C Josiassen; Patrick F Sullivan
Journal:  Am J Psychiatry       Date:  2018-05-01       Impact factor: 18.112

10.  Understanding domains that influence perceived stigma in individuals with Huntington disease.

Authors:  Nicholas R Boileau; Jane S Paulsen; Rebecca E Ready; Elizabeth A Hahn; Jin-Shei Lai; Noelle E Carlozzi
Journal:  Rehabil Psychol       Date:  2020-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.